CITIGROUP INC

Position in AVTX — Avalo Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,275,378

+$1,254,622 QoQ

Shares Held

69,014

+5938.0% QoQ

Ownership

0.129%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 126 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. AVTX ranks #130 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	706,968	$351,172,214
2	REGN	Regeneron Pharmaceuticals, Inc.	346,637	$216,142,034
3	MRNA	Moderna, Inc.	2,165,414	$151,643,941
4	ROIV	Roivant Sciences Ltd.	2,225,190	$78,749,472
5	ALNY	Alnylam Pharmaceuticals, Inc.	227,786	$68,570,419
6	INCY	Incyte Corp	586,431	$66,477,817
7	BBIO	BridgeBio Pharma, Inc.	864,101	$64,358,241
8	RVMD	Revolution Medicines, Inc.	247,052	$46,267,897

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,275,378	69,014	+5938.0%	Shares	Defined	2026-08-03
2025-12-31	$20,756	1,143	+185.8%	Shares	Defined	2026-02-13
2025-09-30	$5,084	400	-82.8%	Shares	Defined	2025-11-10
2022-06-30	$1,160	2,321	+2.4%	Shares	Defined	2022-08-10
2022-03-31	$1,642	2,266	-87.2%	Shares	Defined	2022-05-12
2021-12-31	$30,147	17,734	+194.0%	Shares	Defined	2022-02-10
2021-09-30	$13,149	6,032	—	Shares	Defined	2021-11-10
2021-06-30 CERC	—	2,519	-11.5%	Shares	Defined	2021-08-10
2021-03-31 CERC	—	2,847	-55.9%	Shares	Defined	2021-05-13
2020-12-31 CERC	—	6,451	+270.5%	Shares	Defined	2021-02-11
2020-09-30 CERC	—	1,741	-55.8%	Shares	Defined	2020-11-12
2020-06-30 CERC	—	3,942	-33.7%	Shares	Defined	2020-08-12
2020-03-31 CERC	—	5,947	—	Shares	Defined	2020-05-12
No filing history on record for this holder in this stock.